{"id":"berdazimer-sodium","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BERDAZIMER SODIUM","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:29:04.118848+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:29:09.791016+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BERDAZIMER SODIUM","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:29:10.070477+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298064/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:29:11.285837+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:37:28.279Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:29:12.851667+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT02667444","phase":"PHASE3","title":"P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2016-02-19","conditions":"Acne Vulgaris","enrollment":1330},{"nctId":"NCT02672332","phase":"PHASE3","title":"P3 Study in Acne Comparing Once Daily SB204 and Vehicle","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2016-02-22","conditions":"Acne Vulgaris","enrollment":1307},{"nctId":"NCT02242760","phase":"PHASE2","title":"P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2014-11","conditions":"Acne Vulgaris","enrollment":213},{"nctId":"NCT02798120","phase":"PHASE3","title":"P3 Long Term Safety Study of Once Daily SB204 in Acne","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2016-05-12","conditions":"Acne Vulgaris","enrollment":601},{"nctId":"NCT03436615","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2018-01-24","conditions":"Molluscum Contagiosum","enrollment":256},{"nctId":"NCT02462187","phase":"PHASE2","title":"Topical NVN1000 for the Treatment of External Genital and Perianal Warts","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2015-06-12","conditions":"Genital Warts, Perianal Warts","enrollment":108},{"nctId":"NCT03927703","phase":"PHASE3","title":"A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2019-06-13","conditions":"Molluscum Contagiosum","enrollment":355},{"nctId":"NCT04535531","phase":"PHASE3","title":"A Phase 3 Molluscum Contagiosum Efficacy and Safety Study","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2020-09-01","conditions":"Molluscum Contagiosum","enrollment":891},{"nctId":"NCT03927716","phase":"PHASE3","title":"A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2019-06-03","conditions":"Molluscum Contagiosum","enrollment":352},{"nctId":"NCT01694810","phase":"PHASE1","title":"Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2012-09","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01755247","phase":"PHASE1","title":"A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2012-11","conditions":"Acne Vulgaris","enrollment":15},{"nctId":"NCT01844752","phase":"PHASE2","title":"A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":153},{"nctId":"NCT02581072","phase":"PHASE1","title":"A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2015-10","conditions":"Acne Vulgaris","enrollment":56},{"nctId":"NCT01844739","phase":"PHASE1","title":"A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":30},{"nctId":"NCT01556698","phase":"PHASE1, PHASE2","title":"Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2011-07","conditions":"Acne Vulgaris, Acne","enrollment":70},{"nctId":"NCT02250430","phase":"PHASE1","title":"A Phase 1 Study Assessing Local Cutaneous Effects of SB204","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2014-09","conditions":"Acne Vulgaris","enrollment":8},{"nctId":"NCT02801903","phase":"PHASE1","title":"Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2016-06-07","conditions":"Acne Vulgaris","enrollment":18},{"nctId":"NCT03431610","phase":"PHASE1","title":"A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2017-11-13","conditions":"Atopic Dermatitis","enrollment":48},{"nctId":"NCT03445013","phase":"PHASE1","title":"A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2017-10-13","conditions":"Psoriasis","enrollment":36},{"nctId":"NCT02164084","phase":"PHASE1","title":"A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris","status":"COMPLETED","sponsor":"Novan, Inc.","startDate":"2014-06","conditions":"Acne Vulgaris","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL4298064"},"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"approved","brandName":"BERDAZIMER SODIUM","genericName":"BERDAZIMER SODIUM","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"2024","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:29:12.851667+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}